222 related articles for article (PubMed ID: 7664083)
21. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
[TBL] [Abstract][Full Text] [Related]
22. Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions.
Weng Z; Rickles RJ; Feng S; Richard S; Shaw AS; Schreiber SL; Brugge JS
Mol Cell Biol; 1995 Oct; 15(10):5627-34. PubMed ID: 7565714
[TBL] [Abstract][Full Text] [Related]
23. Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain.
Hane M; Lowin B; Peitsch M; Becker K; Tschopp J
FEBS Lett; 1995 Oct; 373(3):265-8. PubMed ID: 7589480
[TBL] [Abstract][Full Text] [Related]
24. High-resolution structure of the diphtheria toxin repressor complexed with cobalt and manganese reveals an SH3-like third domain and suggests a possible role of phosphate as co-corepressor.
Qiu X; Pohl E; Holmes RK; Hol WG
Biochemistry; 1996 Sep; 35(38):12292-302. PubMed ID: 8823163
[TBL] [Abstract][Full Text] [Related]
25. Structure of the N-terminal SH3 domain of GRB2 complexed with a peptide from the guanine nucleotide releasing factor Sos.
Terasawa H; Kohda D; Hatanaka H; Tsuchiya S; Ogura K; Nagata K; Ishii S; Mandiyan V; Ullrich A; Schlessinger J
Nat Struct Biol; 1994 Dec; 1(12):891-7. PubMed ID: 7773778
[TBL] [Abstract][Full Text] [Related]
26. A binding event converted into a folding event.
Martín-Sierra FM; Candel AM; Casares S; Filimonov VV; Martínez JC; Conejero-Lara F
FEBS Lett; 2003 Oct; 553(3):328-32. PubMed ID: 14572645
[TBL] [Abstract][Full Text] [Related]
27. The high-resolution NMR structure of the R21A Spc-SH3:P41 complex: understanding the determinants of binding affinity by comparison with Abl-SH3.
Casares S; Ab E; Eshuis H; Lopez-Mayorga O; van Nuland NA; Conejero-Lara F
BMC Struct Biol; 2007 Apr; 7():22. PubMed ID: 17407569
[TBL] [Abstract][Full Text] [Related]
28. The tryptophan switch: changing ligand-binding specificity from type I to type II in SH3 domains.
Fernandez-Ballester G; Blanes-Mira C; Serrano L
J Mol Biol; 2004 Jan; 335(2):619-29. PubMed ID: 14672668
[TBL] [Abstract][Full Text] [Related]
29. The role of water molecules in the binding of class I and II peptides to the SH3 domain of the Fyn tyrosine kinase.
Camara-Artigas A; Ortiz-Salmeron E; Andujar-Sánchez M; Bacarizo J; Martin-Garcia JM
Acta Crystallogr F Struct Biol Commun; 2016 Sep; 72(Pt 9):707-12. PubMed ID: 27599862
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure analysis and solution studies of human Lck-SH3; zinc-induced homodimerization competes with the binding of proline-rich motifs.
Romir J; Lilie H; Egerer-Sieber C; Bauer F; Sticht H; Muller YA
J Mol Biol; 2007 Feb; 365(5):1417-28. PubMed ID: 17118402
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain.
Lee CH; Saksela K; Mirza UA; Chait BT; Kuriyan J
Cell; 1996 Jun; 85(6):931-42. PubMed ID: 8681387
[TBL] [Abstract][Full Text] [Related]
32. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef.
Arold S; O'Brien R; Franken P; Strub MP; Hoh F; Dumas C; Ladbury JE
Biochemistry; 1998 Oct; 37(42):14683-91. PubMed ID: 9778343
[TBL] [Abstract][Full Text] [Related]
33. Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain.
Pisabarro MT; Serrano L
Biochemistry; 1996 Aug; 35(33):10634-40. PubMed ID: 8718852
[TBL] [Abstract][Full Text] [Related]
34. NMR solution structure of the tandem Src homology 3 domains of p47phox complexed with a p22phox-derived proline-rich peptide.
Ogura K; Nobuhisa I; Yuzawa S; Takeya R; Torikai S; Saikawa K; Sumimoto H; Inagaki F
J Biol Chem; 2006 Feb; 281(6):3660-8. PubMed ID: 16326715
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the proline-rich region of mouse MAPKAP kinase 2: influence on catalytic properties and binding to the c-abl SH3 domain in vitro.
Plath K; Engel K; Schwedersky G; Gaestel M
Biochem Biophys Res Commun; 1994 Sep; 203(2):1188-94. PubMed ID: 8093038
[TBL] [Abstract][Full Text] [Related]
36. The 1.1 A resolution crystal structure of the p130cas SH3 domain and ramifications for ligand selectivity.
Wisniewska M; Bossenmaier B; Georges G; Hesse F; Dangl M; Künkele KP; Ioannidis I; Huber R; Engh RA
J Mol Biol; 2005 Apr; 347(5):1005-14. PubMed ID: 15784259
[TBL] [Abstract][Full Text] [Related]
37. Structural and thermodynamic characterization of the interaction of the SH3 domain from Fyn with the proline-rich binding site on the p85 subunit of PI3-kinase.
Renzoni DA; Pugh DJ; Siligardi G; Das P; Morton CJ; Rossi C; Waterfield MD; Campbell ID; Ladbury JE
Biochemistry; 1996 Dec; 35(49):15646-53. PubMed ID: 8961927
[TBL] [Abstract][Full Text] [Related]
38. Dynamic interaction of CD2 with the GYF and the SH3 domain of compartmentalized effector molecules.
Freund C; Kühne R; Yang H; Park S; Reinherz EL; Wagner G
EMBO J; 2002 Nov; 21(22):5985-95. PubMed ID: 12426371
[TBL] [Abstract][Full Text] [Related]
39. Crystallization by capillary counter-diffusion and structure determination of the N114A mutant of the SH3 domain of Abl tyrosine kinase complexed with a high-affinity peptide ligand.
Cámara-Artigas A; Palencia A; Martínez JC; Luque I; Gavira JA; García-Ruiz JM
Acta Crystallogr D Biol Crystallogr; 2007 May; 63(Pt 5):646-52. PubMed ID: 17452790
[TBL] [Abstract][Full Text] [Related]
40. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
